Virtual screening of combihatorial libraries across a gene family: In search of inhibitors of Giardia lamblia guanine phosphoribosyltransferase

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2571-2576

  Aronov, A M ^a   Munagala, N R ^a   Kuntz, I D ^a   Wang, C C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE INHIBITOR; PHTHALIMIDE DERIVATIVE; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG; ANTIPARASITIC AGENT;

ARTICLE; CONCENTRATION RESPONSE; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; GIARDIA LAMBLIA; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SENSITIVITY; ENZYMOLOGY; PROTEIN CONFORMATION;

ANIMALS; ANTIPARASITIC AGENTS; DRUG DESIGN; GIARDIA LAMBLIA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MODELS, MOLECULAR; PARASITIC SENSITIVITY TESTS; PHTHALIMIDES; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034741975     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2571-2576.2001     Document Type: Article

References (34)

1. The biology of Giardia spp.
2. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase
3. Rational design of novel antimicrobials: Blocking purine salvage in a parasitic protozoan
4. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: Elucidation of a novel binding mode for a 2-amino-N-6-substituted adenosine
5. Isolation, sequencing and expression of the gene encoding hypoxanthine-guanine-xanthine phosphoribosyltransferase of Tritrichomonas foetus
6. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase
7. Structure-based inhibitor design
8. The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP
9. Critical evaluation of search algorithms for automated molecular docking and database screening
10. A 1.4 Å crystal structure for the hypoxanthine phosphoribosyltransferase of Trypanosoma cruzi
11. Designer drugs: Pipe-dreams or realities?
12. A flexible loop at the dimer interface is a part of the active site of the adjacent monomer of Escherichia coli orotate phosphoribosyltransferase
13. Crystal structures of the Toxoplasma gondii hypoxanthine-guanine phosphoribosyltransferase-GMP and -IMP complexes: Comparison of purine binding interactions with the XMP complex
14. Differential inhibitory effects of GMP-2′,3′-dialdehyde on human and schistosomal hypoxanthineguanine phosphoribosyltransferases
15. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines
16. Structure-based design of parasitic protease inhibitors
17. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
18. Properties and substrate specificity of a purine phosphoribosyltransferase from the human malaria parasite Plasmodium falciparum
19. Structure-based inhibitor design by using protein models for the development of antiparasitic agents
20. The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and α-D-5-phosphoribosyl-1-pyrophosphate
21. Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop
22. The 2.0 Å structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor
23. Crystal structures of Giardia lamblia guanine phosphoribosyltransferase at 1.75 Å
24. The 2.0 angstrom structure of human hypoxanthineguanine phosphoribosyltransferase in complex with a transition-state analog inhibitor
25. Cloning, expression and characterization of an unusual guanine phosphoribosyltransferase from Giardia lamblia
26. Rational design of novel antimicrobials: Blocking purine salvage in a parasitic protozoan
27. Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyl-transferase from the protozoan parasite Tritrichomonas foetus
28. Structures of free and complexed forms of Escherichia coli xanthine-guanine phosphoribosyltransferase
29. Virtual screening - An overview
30. Parasite enzymes as potential targets for antiparasitic chemotherapy
31. Validating targets for antiparasite chemotherapy
32. Purine salvage networks in Giardia lamblia
33. Steady-state kinetics of the schistosomal hypoxanthine-guanine phosphoribosyltransferase